Advances in Materials Science and Engineering, 2023 Advances in Materials Science and Engineering
doaj +1 more source
3D Modeling of Epithelial Tumors-The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology. [PDF]
Int J Mol Sci, 2021 Trivedi P +5 more
europepmc +1 more source
Molecular Oncology, EarlyView.LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Advances in Materials Science and Engineering, 2023 Advances in Materials Science and Engineering
doaj +1 more source
CEACAM1 participation in breast cancer progression
Molecular Oncology, EarlyView.In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
M13 virus/single-walled carbon nanotubes as a materials platform for energy devices and biomedical applications [PDF]
, 2011 Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2011.This electronic version was submitted by the student author.
Yi, Hyunjung
core
Retracted: Mechanical Behavior of Silica Fume Concrete Filled with Steel Tubular Composite Column
Advances in Materials Science and Engineering, 2023 Advances in Materials Science and Engineering
doaj +1 more source
An Integrated Computational Materials Engineering Framework to Analyze the Failure Behaviors of Carbon Fiber Reinforced Polymer Composites for Lightweight Vehicle Applications. [PDF]
Compos Sci Technol, 2021 Sun Q, Zhou G, Meng Z, Jain M, Su X.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Molecular Oncology, EarlyView.Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Monolithic integration of three-five semiconductor materials and devices with silicon
, 1999 Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 1999.Includes bibliographical references (p. 145-152).by Steve M.
Ting, Steve M. (Steve Ming), 1973-
core